tirzepatide weight loss treatment nj science is evolving. 💉 One medication getting a lot of attention right now is Tirzepatide. Originally developed to treat type 2 diabetes, it's now being used to support weight loss Mounjaro® & Zepbound™ (Tirzepatide) Weight-Loss

Diabetic kidney disease, a common complication in patients with type 2 diabetes mellitus, is associated with a markedly increased morbidity and mortality, especially of cardiovascular origin, and faster progression to end-stage renal disease

Injectable Wegovy produces weight loss of around 1520%+, and Zepbound (a dual GIP/GLP-1 agonist) has shown over 20% in trials

I was more focused on what she was doing and her values and who she was as a person. Dr Rebecca Puhl, a psychologist who studies weight stigma at the University of Connecticut and has previously consulted for Eli Lilly, the manufacturer of Mounjaro, says people sometimes hide their GLP-1 use

The main difference is the glucagon component in retatrutide, which can produce more noticeable energy shifts and temperature changes in the first 24 hours

Like all GLP 1 medicines, it works best when combined with sustainable changes to nutrition, activity, sleep, and eating habits

As of June 1, 2026, there are 3,848 lawsuits pending in the federal multidistrict litigation (MDL) for general GLP-1 drug injuries and 146 pending lawsuits in the GLP-1 vision loss (NAION) MDL